Cargando…
Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer—Systematic Review
According to current guidelines, the current treatment for locally advanced rectal cancer is neoadjuvant therapy, followed by a total mesorectal excision. However, radiosensitivity tends to differ among patients due to tumor heterogeneity, making it difficult to predict the possible outcomes of the...
Autores principales: | Smolskas, Edgaras, Mikulskytė, Goda, Sileika, Ernestas, Suziedelis, Kestutis, Dulskas, Audrius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181431/ https://www.ncbi.nlm.nih.gov/pubmed/35682714 http://dx.doi.org/10.3390/ijms23116040 |
Ejemplares similares
-
3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment
por: Kunigenas, Linas, et al.
Publicado: (2020) -
Low Anterior Resection Syndrome: What Have We Learned Assessing a Large Population? †
por: Dulskas, Audrius, et al.
Publicado: (2022) -
Hand Assisted Laparoscopic Surgery for Colorectal Cancer: Surgical and Oncological Outcomes from a Single Tertiary Referral Centre
por: Samalavicius, Narimantas Evaldas, et al.
Publicado: (2022) -
Transanal Endoscopic Microsurgery for Patients With Rectal Tumors: A Single Institution's Experience
por: Dulskas, Audrius, et al.
Publicado: (2017) -
Transanal endoscopic microsurgery for rectal adenomas: single center experience
por: Samalavicius, Narimantas Evaldas, et al.
Publicado: (2015)